| Literature DB >> 17645719 |
Anil Vaidya1, A S Muthusamy, V G Hadjianastassiou, D Roy, D E Elker, P Moustafellos, A Muktadir, S Sinha, P J Friend.
Abstract
Pancreas graft loss due to venous thrombosis is the leading non-immunological cause for graft failure following kidney-pancreas transplantation. Thromboelastography (TEG)-directed anticoagulation protocol has shown that approximately one-third of the patients undergoing pancreas transplantation require therapeutic anticoagulation to prevent the occurrence of graft thrombosis. This article presents the argument for individualised anticoagulation in these patients based on their TEG tracings and suggests the use of TEG in patients undergoing pancreas transplantation.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17645719 DOI： 10.1111/j.1399-0012.2007.00689.x
Source DB: PubMed Journal: Clin Transplant ISSN： 0902-0063 Impact factor: 2.863